Delivery Order SPE2DB22D3301-SPE2DB24FZ3XF

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $42,379.35 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 250 mg vials of the medication Orencia. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Orencia 125 mg/ml syringes. The contract has a ceiling value of $15,354.82 and an ultimate completion date of August 22, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to...
The U.S. government awarded a firm fixed-price delivery order contract worth $37,356.84 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 125 mg/mL Orencia syringes. This contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 250 mg vials of the medication Orencia. The contract has a total ceiling value of $14,514.44 and a performance period through May 2, 2025. It is a firm fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of ORENCIA 250 MG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a firm-fixed price delivery order with a ceiling value of $7,214.91 and a period of performance through July 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999, which enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,402.97 firm-fixed-price delivery order is for the supply of Orencia 250 mg vials, with a completion date of November 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 250 mg vials of the pharmaceutical drug Orencia. The contract is valued at $30,914.07 and has a period of performance ending on August 26, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,566.80 Firm Fixed Price delivery order is for the supply of ORENCIA 250 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a $9,234.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Orencia 250 mg vials, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 250 mg vials of the drug Orencia. The $15,797.35 Firm Fixed Price Delivery Order has an ultimate completion date of December 17, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ3XF
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $14,872.57 to Amerisourcebergen Drug Corp for the supply of 250 mg vials of the pharmaceutical product Orencia. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is scheduled for completion by September 4, 2024.

Generated 12/3/24, 9:55 AM